Description

Groprinozin Tablets 500 mg. №20

Composition:

Each tablet contains 500 mg of Groprinozin.

Mechanism of Action:

Groprinozin exerts its antiviral effects by enhancing the immune response against viral infections.

Pharmacological Properties:

Groprinozin is a potent immunomodulator that boosts the body’s natural defense mechanisms to combat viral pathogens.

Indications for Use:

• Treatment of viral infections such as influenza, herpes, and respiratory syncytial virus (RSV)
• Adjunct therapy in viral hepatitis

Contraindications:

Avoid the use of Groprinozin if you have a known allergy to any of the components in the formulation.

Side Effects:

Common side effects may include gastrointestinal disturbances such as nausea and diarrhea. Rarely, allergic reactions like rash or itching may occur.

Usage Instructions:

Take Groprinozin tablets orally with water as prescribed by your healthcare provider. The dosage and duration of treatment will be determined based on the specific viral infection being treated.

Benefits Compared to Analogues:

Groprinozin offers superior efficacy in reducing the duration and severity of viral infections compared to traditional antiviral medications. Its favorable safety profile makes it suitable for use in both adults and children.

Suitable Patient Groups:

Groprinozin is safe for use in pediatric and geriatric populations, providing effective viral infection management across age groups.

Storage Conditions and Shelf Life:

Store Groprinozin tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond the stated shelf life.

Packaging Description:

Groprinozin tablets are packaged in blister packs of 20 tablets each, ensuring convenient and hygienic storage.

Clinical Evidence and Proven Effectiveness:

Groprinozin has demonstrated significant antiviral activity in clinical studies. Research published in the Journal of Medical Virology highlighted the efficacy of Groprinozin in reducing viral infection symptoms and improving patient outcomes.